Kyverna Therapeutics, Inc. (NASDAQ:KYTX) IPO
IPO
Priced at US$22.00 a share on Feb 7, 2024.
- Price
- US$22.00 a share
- Shares offered
- 14,500,000 shares of common stock
- Offering size
- US$319 million
- Underwriters' option
- Up to 2,175,000 more shares
- Underwriters
- J.P. Morgan, Morgan Stanley, Leerink Partners, Wells Fargo Securities · In the order on the cover
- Shares delivered
- On or about Feb 12, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Oct 5, 2023 |
| Filed publicly | Jan 16, 2024 |
| Amended twice | Newest Feb 6, 2024 |
| Shares registered with an exchange | Feb 5, 2024 |
| Declared effective by the SEC | Feb 7, 2024 |
| Final prospectus, with the price | Feb 8, 2024 |
Filings
From the cover of the final prospectus (424B4) filed Feb 8, 2024